119 related articles for article (PubMed ID: 7731694)
1. Human ERG is a proto-oncogene with mitogenic and transforming activity.
Hart AH; Corrick CM; Tymms MJ; Hertzog PJ; Kola I
Oncogene; 1995 Apr; 10(7):1423-30. PubMed ID: 7731694
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of apoptosis by normal and aberrant Fli-1 and erg proteins involved in human solid tumors and leukemias.
Yi H; Fujimura Y; Ouchida M; Prasad DD; Rao VN; Reddy ES
Oncogene; 1997 Mar; 14(11):1259-68. PubMed ID: 9178886
[TBL] [Abstract][Full Text] [Related]
3. The ERGB/Fli-1 gene: isolation and characterization of a new member of the family of human ETS transcription factors.
Watson DK; Smyth FE; Thompson DM; Cheng JQ; Testa JR; Papas TS; Seth A
Cell Growth Differ; 1992 Oct; 3(10):705-13. PubMed ID: 1445800
[TBL] [Abstract][Full Text] [Related]
4. erg, an ets-related gene, codes for sequence-specific transcriptional activators.
Reddy ES; Rao VN
Oncogene; 1991 Dec; 6(12):2285-9. PubMed ID: 1766675
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of Erg and Ets-2 transcription factors is associated with genetic changes at 21q22.2-22.3 in immortal and cervical carcinoma cell lines.
Simpson S; Woodworth CD; DiPaolo JA
Oncogene; 1997 May; 14(18):2149-57. PubMed ID: 9174050
[TBL] [Abstract][Full Text] [Related]
6. ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction.
Venanzoni MC; Robinson LR; Hodge DR; Kola I; Seth A
Oncogene; 1996 Mar; 12(6):1199-1204. PubMed ID: 8649821
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of the AML1 proto-oncoprotein in NIH3T3 cells leads to neoplastic transformation depending on the DNA-binding and transactivational potencies.
Kurokawa M; Tanaka T; Tanaka K; Ogawa S; Mitani K; Yazaki Y; Hirai H
Oncogene; 1996 Feb; 12(4):883-92. PubMed ID: 8632911
[TBL] [Abstract][Full Text] [Related]
8. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness.
Foos G; Hauser CA
Oncogene; 2000 Nov; 19(48):5507-16. PubMed ID: 11114728
[TBL] [Abstract][Full Text] [Related]
9. The COOH-terminal domain of FLI-1 is necessary for full tumorigenesis and transcriptional modulation by EWS/FLI-1.
Arvand A; Welford SM; Teitell MA; Denny CT
Cancer Res; 2001 Jul; 61(13):5311-7. PubMed ID: 11431376
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the human stress response gene GADD153 expression: role of ETS1 and FLI-1 gene products.
Seth A; Giunta S; Franceschil C; Kola I; Venanzoni MC
Cell Death Differ; 1999 Sep; 6(9):902-7. PubMed ID: 10510472
[TBL] [Abstract][Full Text] [Related]
11. The EndoA enhancer contains multiple ETS binding site repeats and is regulated by ETS proteins.
Seth A; Robinson L; Panayiotakis A; Thompson DM; Hodge DR; Zhang XK; Watson DK; Ozato K; Papas TS
Oncogene; 1994 Feb; 9(2):469-77. PubMed ID: 7507230
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic activation of the tyrosine kinase domain of the human trk proto-oncogene by fusion to a cell adhesion molecule.
Albor A; Thraves PJ; Dritschilo A; Notario V
Oncogene; 1996 Oct; 13(8):1755-63. PubMed ID: 8895522
[TBL] [Abstract][Full Text] [Related]
13. Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein.
Hahm KB; Cho K; Lee C; Im YH; Chang J; Choi SG; Sorensen PH; Thiele CJ; Kim SJ
Nat Genet; 1999 Oct; 23(2):222-7. PubMed ID: 10508522
[TBL] [Abstract][Full Text] [Related]
14. Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody.
Seth A; Robinson L; Thompson DM; Watson DK; Papas TS
Oncogene; 1993 Jul; 8(7):1783-90. PubMed ID: 8510925
[TBL] [Abstract][Full Text] [Related]
15. Transforming activity of EWS/FLI is not strictly dependent upon DNA-binding activity.
Jaishankar S; Zhang J; Roussel MF; Baker SJ
Oncogene; 1999 Sep; 18(40):5592-7. PubMed ID: 10523836
[TBL] [Abstract][Full Text] [Related]
16. Fli-1b is generated by usage of differential splicing and alternative promoter.
Dhulipala PD; Lee L; Rao VN; Reddy ES
Oncogene; 1998 Sep; 17(9):1149-57. PubMed ID: 9764825
[TBL] [Abstract][Full Text] [Related]
17. Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene.
Lessnick SL; Braun BS; Denny CT; May WA
Oncogene; 1995 Feb; 10(3):423-31. PubMed ID: 7845667
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of the ets genes and their products.
Watson DK; Ascione R; Papas TS
Crit Rev Oncog; 1990; 1(4):409-36. PubMed ID: 1964597
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
[TBL] [Abstract][Full Text] [Related]
20. EWS-erg and EWS-Fli1 fusion transcripts in Ewing's sarcoma and primitive neuroectodermal tumors with variant translocations.
Giovannini M; Biegel JA; Serra M; Wang JY; Wei YH; Nycum L; Emanuel BS; Evans GA
J Clin Invest; 1994 Aug; 94(2):489-96. PubMed ID: 8040301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
